P
INSM icon

&Partners’s Insmed INSM Stock Holding History

&Partners’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.34M Buy
8,198
+939
+13% +$144K 0.01% 1134
2025
Q4 		$1.26M Buy
7,259
+1,213
+20% +$221K 0.01% 1099
2025
Q3 		$871K Buy
6,046
+330
+6% +$40.4K 0.01% 1155
2025
Q2 		$575K Buy
5,716
+406
+8% +$31K ﹤0.01% 1284
2025
Q1 		$414K Buy
5,310
+377
+8% +$28.8K ﹤0.01% 1228
2024
Q4 		$341K Buy
4,933
+31
+0.6% +$2.23K ﹤0.01% 1268
2024
Q3 		$358K Buy
4,902
+425
+9% +$31.4K 0.01% 1018
2024
Q2 		$300K Buy
+4,477
New +$174K 0.01% 716

Other funds holding INSM

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

&Partners's INSM Position: Q1 2026 in Review

&Partners increased its Insmed (INSM) stake by 13% in Q1 2026, buying an estimated $144K and bringing the position to 8,198 shares worth $1.34M. The position accounts for 0.01% of the portfolio, ranked #1134.

&Partners first reported a position in INSM in Q2 2024 and has held it in 8 quarters since. 669 funds tracked by Wall St. Rank hold INSM as of Q1 2026.

  • &Partners held 8,198 shares of Insmed worth $1.34M as of Q1 2026.
  • &Partners bought 939 Insmed shares in Q1 2026, an estimated $144K.
  • Insmed made up 0.01% of &Partners's portfolio in Q1 2026, its #1134 holding.
  • &Partners first reported a position in Insmed in Q2 2024 and has held it in 8 quarters since.
  • 669 funds tracked by Wall St. Rank held Insmed as of Q1 2026.

Based on &Partners's 13F filing for Q1 2026, filed 15 May 2026.